|
|
||||||||
Dear Sir
We agree with many comments expressed by Dr. F. DeWolfe Miller about our study, High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in the Nile Delta: a pilot study. First, Dr. Miller is correct in stating that he and his collaborators were the first to report the age-specific prevalence of HEV in an Egyptian community. We appreciate his pointing out the 1995 paper by Kamel and others, which we overlooked and should have recognized in our report. Although the serologic profiles by age group differ somewhat between our two study villages, both show serologic evidence of HEV infection in children and high, but reasonably static, seroprevalence rates of HEV among adults. Although we studied fewer villagers, we believe the numbers were sufficient to suggest that the mechanism and dynamics of HEV transmission may be different between the two Nile Delta study villages.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |